145 related articles for article (PubMed ID: 38018884)
21. Cytotoxic activity of new acetoxycoumarin derivatives in cancer cell lines.
Musa MA; Badisa VL; Latinwo LM; Cooperwood J; Sinclair A; Abdullah A
Anticancer Res; 2011 Jun; 31(6):2017-22. PubMed ID: 21737617
[TBL] [Abstract][Full Text] [Related]
22. In vitro inhibition studies of coumarin derivatives on Bos taurus enolase and elucidating their interaction by molecular docking, molecular dynamics simulations and MMGB(PB)SA binding energy calculation.
Sariyer E; Kocer S; Danis O; Turgut-Balik D
Bioorg Chem; 2021 May; 110():104796. PubMed ID: 33799179
[TBL] [Abstract][Full Text] [Related]
23. Coumarin: a promising scaffold for anticancer agents.
Kaur M; Kohli S; Sandhu S; Bansal Y; Bansal G
Anticancer Agents Med Chem; 2015; 15(8):1032-48. PubMed ID: 25553437
[TBL] [Abstract][Full Text] [Related]
24. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
[TBL] [Abstract][Full Text] [Related]
25. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
26. Coumarins: old compounds with novel promising therapeutic perspectives.
Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, Antioxidant and Antiproliferative Evaluation, Molecular Docking and DFT Studies of Some Novel Coumarin and Fused Coumarin Derivatives.
Gouda MAS; Salem MAI; Marzouk MI; Mahmoud NFH; Ismail MF
Chem Biodivers; 2023 Jul; 20(7):e202300706. PubMed ID: 37321977
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
[TBL] [Abstract][Full Text] [Related]
30. Identification of phenazine analogue as a novel scaffold for thioredoxin reductase I inhibitors against Hep G2 cancer cell lines.
Liao J; Wang L; Wu Z; Wang Z; Chen J; Zhong Y; Jiang F; Lu Y
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1158-1163. PubMed ID: 31179772
[TBL] [Abstract][Full Text] [Related]
31. Translational role of natural coumarins and their derivatives as anticancer agents.
Menezes JC; Diederich M
Future Med Chem; 2019 May; 11(9):1057-1082. PubMed ID: 31140865
[TBL] [Abstract][Full Text] [Related]
32. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Dandriyal J; Singla R; Kumar M; Jaitak V
Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
[TBL] [Abstract][Full Text] [Related]
33. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
34. A furanyl acryl conjugated coumarin as an efficient inhibitor and a highly selective off-on fluorescent probe for covalent labelling of thioredoxin reductase.
Huang L; Chen Y; Liang B; Xing B; Wen G; Wang S; Yue X; Zhu C; Du J; Bu X
Chem Commun (Camb); 2014 Jul; 50(53):6987-90. PubMed ID: 24844612
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluations of diverse Michael acceptor-based phenazine hybrid molecules as TrxR1 inhibitors.
Zhong Y; Liu J; Cheng X; Zhang H; Zhang C; Xia Z; Wu Z; Zhang L; Zheng Y; Gao Z; Jiang Z; Wang Z; Huang D; Lu Y; Jiang F
Bioorg Chem; 2021 Apr; 109():104736. PubMed ID: 33640630
[TBL] [Abstract][Full Text] [Related]
37. Benzazole Substituted Iminocoumarins as Potential Antioxidants with Antiproliferative Activity.
Perin N; Cindrić M; Vervaeke P; Liekens S; Mašek T; Starčević K; Hranjec M
Med Chem; 2021; 17(1):13-20. PubMed ID: 31849290
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols.
Bakulina O; Bannykh A; Jovanović M; Domračeva I; Podolski-Renić A; Žalubovskis R; Pešić M; Dar'in D; Krasavin M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):665-671. PubMed ID: 30746961
[TBL] [Abstract][Full Text] [Related]
39. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells.
Maleki EH; Bahrami AR; Sadeghian H; Matin MM
Toxicol In Vitro; 2020 Mar; 63():104745. PubMed ID: 31830504
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
Lv N; Sun M; Liu C; Li J
Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
